- Home
- NEO vs BBN Comparison
NEO vs BBN Comparison
Compare NEO & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- BBN
- Stock Information
- Founded
- NEO 2001
- BBN 1983
- Country
- NEO United States
- BBN United States
- Employees
- NEO N/A
- BBN N/A
- Industry
- NEO Precision Instruments
- BBN Finance Companies
- Sector
- NEO Health Care
- BBN Finance
- Exchange
- NEO Nasdaq
- BBN Nasdaq
- Market Cap
- NEO 1.2B
- BBN 1.0B
- IPO Year
- NEO 1999
- BBN N/A
- Fundamental
- Price
- NEO $10.60
- BBN $17.06
- Analyst Decision
- NEO Buy
- BBN
- Analyst Count
- NEO 10
- BBN 0
- Target Price
- NEO $12.56
- BBN N/A
- AVG Volume (30 Days)
- NEO 3.0M
- BBN 231.8K
- Earning Date
- NEO 10-28-2025
- BBN 01-01-0001
- Dividend Yield
- NEO N/A
- BBN 6.90%
- EPS Growth
- NEO N/A
- BBN N/A
- EPS
- NEO N/A
- BBN N/A
- Revenue
- NEO $709,162,000.00
- BBN N/A
- Revenue This Year
- NEO $10.74
- BBN N/A
- Revenue Next Year
- NEO $9.85
- BBN N/A
- P/E Ratio
- NEO N/A
- BBN N/A
- Revenue Growth
- NEO 10.10
- BBN N/A
- 52 Week Low
- NEO $4.72
- BBN $14.33
- 52 Week High
- NEO $19.12
- BBN $18.36
- Technical
- Relative Strength Index (RSI)
- NEO 59.78
- BBN 56.83
- Support Level
- NEO $9.89
- BBN $16.87
- Resistance Level
- NEO $10.44
- BBN $17.36
- Average True Range (ATR)
- NEO 0.52
- BBN 0.18
- MACD
- NEO -0.03
- BBN -0.01
- Stochastic Oscillator
- NEO 67.92
- BBN 44.31
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.